X

Trial Profile

A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 28 Apr 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bexagliflozin (Primary)
Indications Type 2 diabetes mellitus
Focus Registrational; Therapeutic Use
Sponsors Theracos

Most Recent Events

27 Apr 2018 Status changed from active, no longer recruiting to completed.
28 Feb 2018 Planned End Date changed from 1 Feb 2018 to 1 Mar 2018.
27 Jan 2018 This trial has been completed in Spain (end date: 2018-01-11)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com